Zydus Lifesciences formerly known as Cadila Healthcare has received Prior Approval Supplement PAS approval from the USFDA to market Mycophenolate Mofetil for Injection USP 500 mgvial US RLD CellCept injection The injection will be manufactured at the groups injectables manufacturing facility at Jarod near Vadodara in Gujarat The Prior Approval Supplement PAS was for a site transfer into the Jarod site This site was recently […]
Themis Medicare announced the approval of its antiviral drug VIRALEXreg by the Drug Controller General of India The drug helps in early relief of the clinical symptoms in mild to moderate Covid-19 patients
Shukra Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 26 March 2022
Ceinsys Tech will hold a meeting of the Board of Directors of the Company on 26 March 2022
Future Lifestyle Fashions announced that an Extra Ordinary General Meeting EGM of the Company will be held on 20 April 2022
Sun Pharma Advanced Research Company has allotted 8426966 equity shares of Re 1 each on conversion of equivalent number of convertible warrants Post the above allotment the paid up capital of the Company has increased from Rs 263452000 263452000 equity shares of face value of Re 1 each fully paid up to Rs 271878966 271878966 equity shares of face value of Re 1 each fully […]
SMS Pharmaceuticals announced the successful completion of remote regulatory assessment by USFDA for its testing facility SMS Pharmaceuticals Central Laboratory Analytical Services in Telangana and received Remote Assessment Report As a result of this remote assessment USFDA does not plan to take or recommend regulatory or enforcement action at this time The Central Laboratory Analytical Services is an independent testing laboratory and this was the […]
Nirbhay Colours India will hold a meeting of the Board of Directors of the Company on 25 March 2022
Precision Containeurs has cancelled the board meeting which was scheduled to be held on 22 March 2022
Ruchi Soya Industries has fixed a price band at Rs 615 to Rs 650 per share for its follow-on public offer The follow-on public offering will open on 24 March 2022 for subscription and will close on 28 March 2022 The FPO consists of fresh issuance of equity shares for an amount aggregating to Rs 4300 crore The issue also includes a reservation of up […]
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
